Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company ...

Cyngn Inc. (the "Company" or "Cyngn") (Nasdaq: CYN) today announced that it will proceed with a 1-for-150 reverse stock split ...

Windtree Therapeutics (WINT) board of directors has approved a 1-for-50 reverse stock split of the Company’s common stock. The Company’s ...

Windtree Therapeutics, Inc. (NasdaqCM: WINT) (“Windtree” or the “Company”), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases, ...

Boxlight Corporation (Nasdaq: BOXL), a leading provider of interactive technology solutions, today announced that its Board of Directors has approved a 1-for-5 reverse stock split (the "Reverse Stock ...

January 2025, the U.S. Securities and Exchange Commission (SEC) approved amendments, both of which are now effective, to The Nasdaq Stock Market ...

The Securities and Exchange Commission (SEC) recently approved rule changes proposed by The Nasdaq Stock Market LLC that impact companies ...

These are the upcoming stock splits for the week of February 17 to February 21, based on TipRanks’ Stock Splits Calendar.

The reverse stock split is intended to regain compliance with the minimum bid price requirement of $1.00 per share of the Company’s common stock for continued listing on The Nasdaq Capital Market.

Aptose Biosciences (APTO) announced that its board of directors has approved, subject to required regulatory and stock exchange approvals, a ...

Detailed price information for Hydrofarm Holdings Group Inc (HYFM-Q) from The Globe and Mail including charting and trades.